Augmentin Dosing for Elderly Patients at Discharge
For elderly patients being discharged on oral amoxicillin-clavulanate (Augmentin), prescribe 875/125 mg twice daily for normal renal function, with mandatory dose reduction to 500/125 mg twice daily or extended intervals for creatinine clearance <30 mL/min.
Standard Dosing for Elderly Patients
The standard adult formulation of amoxicillin-clavulanate is 875/125 mg twice daily or 500/125 mg three times daily 1. The clavulanate component is fixed at 125 mg per dose in adult formulations due to tolerability concerns, particularly gastrointestinal side effects 2, 3.
Key consideration: Elderly patients demonstrate approximately 90% higher systemic exposure to amoxicillin and 60% higher exposure to clavulanate compared to younger adults, even though elimination half-lives remain similar 4. This increased exposure is well-tolerated but underscores the importance of renal function assessment.
Renal Function Adjustments (Critical)
Mandatory dose modifications based on creatinine clearance:
- CrCl >30 mL/min: Standard dosing (875/125 mg twice daily or 500/125 mg three times daily)
- CrCl 10-30 mL/min: Reduce to 500/125 mg twice daily or extend interval to 875/125 mg once daily
- CrCl <10 mL/min: 500/125 mg once daily 5, 6
The differential effect of renal impairment is crucial: amoxicillin clearance decreases more dramatically than clavulanate clearance with declining renal function, resulting in disproportionate amoxicillin accumulation 5. The ratio of amoxicillin to clavulanate AUC increases from approximately 5:1 in normal renal function to 14-15:1 in severe renal impairment or dialysis 5, 6.
For hemodialysis patients: Administer 500/125 mg after each dialysis session, as both components are significantly removed by dialysis (extraction ratios: clavulanate 0.74, amoxicillin 0.44) 6.
β-Lactam Allergy Alternatives
For documented Type I hypersensitivity (immediate) reactions to β-lactams:
- Respiratory fluoroquinolones: Levofloxacin 750 mg daily or moxifloxacin 400 mg daily 7
- For skin/soft tissue infections: Doxycycline 100 mg twice daily or TMP-SMX 1-2 double-strength tablets twice daily 8
- Avoid: Cross-reactivity risk with cephalosporins in true IgE-mediated penicillin allergy
For non-Type I reactions (e.g., rash without anaphylaxis): Consider cephalosporins as alternatives, though this requires careful clinical judgment 7.
Clinical Implementation Algorithm
- Assess renal function: Calculate or measure creatinine clearance (Cockcroft-Gault equation accounts for age and reduced muscle mass in elderly)
- Verify allergy history: Distinguish true Type I hypersensitivity from other reactions
- Select dose:
- Normal renal function (CrCl >30): 875/125 mg twice daily
- Moderate impairment (CrCl 10-30): 500/125 mg twice daily
- Severe impairment (CrCl <10): 500/125 mg once daily
- Counsel on administration: Take at the start of meals to minimize GI intolerance and enhance clavulanate absorption 1
Important Caveats
Gastrointestinal tolerability: The clavulanate component is primarily responsible for diarrhea and GI side effects, including Clostridioides difficile risk 2, 3. Consider whether amoxicillin alone (without clavulanate) would suffice for the indication, as many respiratory infections do not require β-lactamase inhibition 3.
Hepatic monitoring: Dose with caution in hepatic impairment and monitor liver function, particularly with prolonged therapy 1.
Duration: Conservative treatment duration is advisable in elderly patients due to underlying anatomic/functional predispositions that complicate infections 9.
Avoid in severe renal impairment without adjustment: Failure to reduce dose appropriately leads to excessive amoxicillin accumulation, though the therapeutic/toxic ratio of β-lactams remains favorable compared to other antibiotic classes 10, 9.